Insiders / Deerfield Mgmt, L.P.

Deerfield Mgmt, L.P.

CIK 1352546personinsiderbeneficial owner
Companies
3
First seen
Feb 6, 2026
Last activity
Jun 18, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Larimar Therapeutics, Inc. · LRMRDirector35,606,97410,622,9575
Parabilis Medicines, Inc. · PBLS10% owner1,880,704940,35216
Nuvalent, Inc. · NUVLDirector3,4443,4441

All securities held

4 positions · latest reported per filing
CompanySecuritySharesAs of
Larimar Therapeutics, Inc.Common Stock35,606,974Feb 27, 2026
Larimar Therapeutics, Inc.Stock Option (Right to Buy)Derivative55,150May 19, 2026
Nuvalent, Inc.Class A Common Stock3,444Jun 16, 2026
Parabilis Medicines, Inc.Voting Common Stock1,880,704Jun 11, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 27, 2026BuyLRMR
Larimar Therapeutics, Inc.
Common Stock
$10.00M+2.0M
+47.53%
6,207,982
5.98% of shares
high
Feb 27, 2026BuyLRMR
Larimar Therapeutics, Inc.
Common Stock
$5.42M+1.1M
+11.36%
10,622,957
10.23% of shares
high
Feb 27, 2026BuyLRMR
Larimar Therapeutics, Inc.
Common Stock
$5.42M+1.1M
+11.36%
10,622,928
10.23% of shares
high
Feb 27, 2026BuyLRMR
Larimar Therapeutics, Inc.
Common Stock
$4.16M+832K
+11.36%
8,153,107
7.85% of shares
high
Jun 16, 2026GrantNUVL
Nuvalent, Inc.
Class A Common Stock
$0+3K
3,444
<0.01% of shares
low
Jun 11, 2026OtherPBLS
Parabilis Medicines, Inc.
Series D Preferred Stock
-465K
-100.00%
0
0.00% of shares
low
Jun 11, 2026OtherPBLS
Parabilis Medicines, Inc.
Series D Preferred Stock
-465K
-100.00%
0
0.00% of shares
low
Jun 11, 2026OtherPBLS
Parabilis Medicines, Inc.
Series C Preferred Stock
-247K
-100.00%
0
0.00% of shares
low
Jun 11, 2026OtherPBLS
Parabilis Medicines, Inc.
Series C Preferred Stock
-247K
-100.00%
0
0.00% of shares
low
Jun 11, 2026OtherPBLS
Parabilis Medicines, Inc.
Series B Preferred Stock
-144K
-100.00%
0
0.00% of shares
low